Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 83


iPCS Cell Modeling of Inherited Cardiac Arrhythmias.

Shinnawi R, Gepstein L.

Curr Treat Options Cardiovasc Med. 2014 Sep;16(9):331. doi: 10.1007/s11936-014-0331-4.


Modeling of arrhythmogenic right ventricular cardiomyopathy with human induced pluripotent stem cells.

Caspi O, Huber I, Gepstein A, Arbel G, Maizels L, Boulos M, Gepstein L.

Circ Cardiovasc Genet. 2013 Dec;6(6):557-68. doi: 10.1161/CIRCGENETICS.113.000188. Epub 2013 Nov 7.


Induced pluripotent stem cell derived cardiomyocytes as models for cardiac arrhythmias.

Hoekstra M, Mummery CL, Wilde AA, Bezzina CR, Verkerk AO.

Front Physiol. 2012 Aug 31;3:346. eCollection 2012.


Molecular mechanisms of inherited ventricular arrhythmias.

Wichter T, Schulze-Bahr E, Eckardt L, Paul M, Levkau B, Meyborg M, Schäfers M, Haverkamp W, Breithardt G.

Herz. 2002 Dec;27(8):712-39. Review.


Drug screening using a library of human induced pluripotent stem cell-derived cardiomyocytes reveals disease-specific patterns of cardiotoxicity.

Liang P, Lan F, Lee AS, Gong T, Sanchez-Freire V, Wang Y, Diecke S, Sallam K, Knowles JW, Wang PJ, Nguyen PK, Bers DM, Robbins RC, Wu JC.

Circulation. 2013 Apr 23;127(16):1677-91. doi: 10.1161/CIRCULATIONAHA.113.001883. Epub 2013 Mar 21.


hiPSC Modeling of Inherited Cardiomyopathies.

Jung G, Bernstein D.

Curr Treat Options Cardiovasc Med. 2014 Jul;16(7):320. doi: 10.1007/s11936-014-0320-7.


Human Induced Pluripotent Stem Cell Models of Inherited Cardiovascular Diseases.

Jiang W, Lan F, Zhang H.

Curr Stem Cell Res Ther. 2014 Oct 16. [Epub ahead of print]


Modeling type 3 long QT syndrome with cardiomyocytes derived from patient-specific induced pluripotent stem cells.

Ma D, Wei H, Zhao Y, Lu J, Li G, Sahib NB, Tan TH, Wong KY, Shim W, Wong P, Cook SA, Liew R.

Int J Cardiol. 2013 Oct 15;168(6):5277-86. doi: 10.1016/j.ijcard.2013.08.015. Epub 2013 Aug 15.


Modeling inherited cardiac disorders.

Sallam K, Kodo K, Wu JC.

Circ J. 2014;78(4):784-94. Epub 2014 Mar 17. Review.


Modeling of catecholaminergic polymorphic ventricular tachycardia with patient-specific human-induced pluripotent stem cells.

Itzhaki I, Maizels L, Huber I, Gepstein A, Arbel G, Caspi O, Miller L, Belhassen B, Nof E, Glikson M, Gepstein L.

J Am Coll Cardiol. 2012 Sep 11;60(11):990-1000. doi: 10.1016/j.jacc.2012.02.066. Epub 2012 Jun 27.


Calcium signaling in human stem cell-derived cardiomyocytes: Evidence from normal subjects and CPVT afflicted patients.

Zhang XH, Morad M.

Cell Calcium. 2015 Dec 15. pii: S0143-4160(15)00173-6. doi: 10.1016/j.ceca.2015.12.002. [Epub ahead of print] Review.


Derivation and cardiomyocyte differentiation of induced pluripotent stem cells from heart failure patients.

Zwi-Dantsis L, Huber I, Habib M, Winterstern A, Gepstein A, Arbel G, Gepstein L.

Eur Heart J. 2013 Jun;34(21):1575-86. doi: 10.1093/eurheartj/ehs096. Epub 2012 May 22.


Cardiac safety pharmacology: from human ether-a-gogo related gene channel block towards induced pluripotent stem cell based disease models.

Kraushaar U, Meyer T, Hess D, Gepstein L, Mummery CL, Braam SR, Guenther E.

Expert Opin Drug Saf. 2012 Mar;11(2):285-98. doi: 10.1517/14740338.2012.639358. Epub 2011 Nov 22. Review.


Modeling heart disease in a dish: from somatic cells to disease-relevant cardiomyocytes.

Zanella F, Lyon RC, Sheikh F.

Trends Cardiovasc Med. 2014 Jan;24(1):32-44. doi: 10.1016/j.tcm.2013.06.002. Epub 2013 Sep 17. Review.


Cardiomyopathy in a dish: using human inducible pluripotent stem cells to model inherited cardiomyopathies.

Kamdar F, Klaassen Kamdar A, Koyano-Nakagawa N, Garry MG, Garry DJ.

J Card Fail. 2015 Sep;21(9):761-70. doi: 10.1016/j.cardfail.2015.04.010. Epub 2015 Apr 28. Review.


Induced pluripotent stem cell-derived cardiomyocytes: a versatile tool for arrhythmia research.

Sinnecker D, Goedel A, Laugwitz KL, Moretti A.

Circ Res. 2013 Mar 15;112(6):961-8. doi: 10.1161/CIRCRESAHA.112.268623. Review.


Gene mutations in cardiac arrhythmias: a review of recent evidence in ion channelopathies.

Hsiao PY, Tien HC, Lo CP, Juang JM, Wang YH, Sung RJ.

Appl Clin Genet. 2013 Jan 18;6:1-13. doi: 10.2147/TACG.S29676. Print 2013.


Modeling Catecholaminergic Polymorphic Ventricular Tachycardia using Induced Pluripotent Stem Cell-derived Cardiomyocytes.

Novak A, Lorber A, Itskovitz-Eldor J, Binah O.

Rambam Maimonides Med J. 2012 Jul 31;3(3):e0015. doi: 10.5041/RMMJ.10086. Print 2012 Jul.


In vitro modeling of ryanodine receptor 2 dysfunction using human induced pluripotent stem cells.

Fatima A, Xu G, Shao K, Papadopoulos S, Lehmann M, Arnáiz-Cot JJ, Rosa AO, Nguemo F, Matzkies M, Dittmann S, Stone SL, Linke M, Zechner U, Beyer V, Hennies HC, Rosenkranz S, Klauke B, Parwani AS, Haverkamp W, Pfitzer G, Farr M, Cleemann L, Morad M, Milting H, Hescheler J, Saric T.

Cell Physiol Biochem. 2011;28(4):579-92. doi: 10.1159/000335753. Epub 2011 Dec 14.


Induced pluripotent stem cells for the study of cardiovascular disease.

Savla JJ, Nelson BC, Perry CN, Adler ED.

J Am Coll Cardiol. 2014 Aug 5;64(5):512-9. doi: 10.1016/j.jacc.2014.05.038. Review.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk